Skip to main content

July 2015

 

 

academics

 

Clinical research courses

In normal plants, a defense hormone that keeps bad bacteria out from the surface as well as inside the plant's roots and actively recruits the good ones has been detected by researchers. For the study, the researcher team introduced 38 strains of bacteria that they had isolated from roots grown in the wild soil into a sterile clay. The researchers showed that when they grew plants in that synthetic soil, the presence of salicylic acid determined which microbes colonized the roots. The findings are published in the Science Express.

IOL Chemicals and Pharmaceuticals  has received US FDA approval for marketing APIs in US after successful inspection of its ibuprofen manufacturing facility situated at Barnala in Punjab. The said facility at Barnala has also been approved by ANVISA Brazil, WHO and MOH Japan. These approvals will help to build and sustaining the growth by its API business in coming years.

Hospira launches generic bivalirudin for injection in US market

The US Food and Drug Administration (FDA) has granted marketing approval for Hospira, Inc.'s bivalirudin for injection, a generic version of The Medicines Company's Angiomax.

Scientists have discovered thousands of toxins hidden deep within the venom of a sea cone snail in Queensland, which may help develop new drugs to treat pain, cancer and other diseases. Researchers used biochemical and bioinformatics tools to develop a new method to analyse the structure of the venom toxins, allowing them to delve deeper than ever before.

(Business Wire India); Biocon Ltd, Asia's premier biopharmaceuticals company, announced today that it has delivered a strong consolidated financial performance for Q1 FY16.

Walk in interview for the post of Trial Coordinator in ACTREC | B.Pharm

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC, Kharghar, Navi Mumbai is the new state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia. ACTREC has the mandate to function as a national centre for treatment, research and education in cancer. TMC is an autonomous grant-in-aid institution of the Department of Atomic Energy (DAE), Government of India. It is registered under the Societies Registration Act (1860) and the Bombay Public Trust Act (1950). Its Governing Council is headed by the Chairman, Atomic Energy Commission, Government of India.

Post: Trial Coordinator

Pharmacist in Office of the CDMO, Keonjhar | 28 Opening

Applications are invited from the eligible candidates by speed post /Regd.Post for the post of Pharmacist in contractual basis as noted below against each category in Keonjhar District.

Post: Pharmacist

NIPER invites Assistant Professor, Professor, Associate Professor

National Institute of Pharmaceutical Education & Research (NIPER), Hyderabad (Established in the year 2007) is a prestigious educational institution of national importance under the aegis of Dept, of Pharmaceuticals, Ministry of Chemicals & Fertilizers, Government of India. NIPER, Hyderabad conducts courses in MS (Pharm), M.Tech (Pharm) in Pharmaceutical Sciences and MBA (Pharm) in Pharma Management for Two years. Students are selected through a national entrance test. Research opportunities also exist for those who would like to pursue their Doctoral Degree. The Institute is mentored by CSIR-Indian Institute of Chemical Technology, Hyderabad a leader in Chemical Technology well known all over the world.

NIPER is now inviting applications for faculty and other position on contractual basis intially for a period of one year which is likely to continue based on the performance of the selected candidate. Candidates will be paid handsome consolidated emoluments.

Post: Assistant Professor, Professor, Associate Professor

Panacea Biotec invites Multiple vacancies

Panacea Biotec is one of India's leading research based health Management Company with well demonstrated R&D, manufacturing and Sales & Marketing capabilities. Panacea Biotec is 2nd largest vaccine producer, 3rd largest Biotechnology Company and amongst the top 50 pharmaceutical companies in India. We are looking for professionals for our operations in bulk antigens. Vaccines & Pharmaceutical plants at Lalru (Punjab) and Baddi (Himachal Pradesh).

Post: Plant Head, AGM, DGM

GSK announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive scientific opinion for its malaria candidate vaccine MosquirixTM, also known as RTS,S, in children aged 6 weeks to 17 months. Following this decision, the World Health Organization (WHO) will now formulate a policy recommendation on use of the vaccine in national immunisation programmes once approved by national regulatory authorities.